These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 34952717)

  • 1. Cutaneous Lupus Erythematosus and Dermatomyositis: Utilizing Assessment Tools for Treatment Efficacy.
    Chong BF; Werth V
    J Invest Dermatol; 2022 Mar; 142(3 Pt B):936-943. PubMed ID: 34952717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in Cutaneous Lupus Erythematosus and Dermatomyositis: A Report from the 4th International Conference on Cutaneous Lupus Erythematosus-An Ongoing Need for International Consensus and Collaborations.
    Concha JSS; Patsatsi A; Marshak-Rothstein A; Liu ML; Sinha AA; Lee LA; Merola JF; Jabbari A; Gudjonsson JE; Chasset F; Jarrett P; Chong B; Arkin L; Fernandez AP; Caproni M; Greenberg SA; Kim HJ; Pearson DR; Femia A; Vleugels RA; Fiorentino D; Fujimoto M; Wenzel J; Werth VP
    J Invest Dermatol; 2019 Feb; 139(2):270-276. PubMed ID: 30243657
    [No Abstract]   [Full Text] [Related]  

  • 3. Adverse cutaneous reactions secondary to hydroxychloroquine in patients with dermatomyositis, lupus erythematosus, and lichen planopilaris.
    Akabane AL; Smith GP
    J Am Acad Dermatol; 2021 Oct; 85(4):1046-1047. PubMed ID: 33607179
    [No Abstract]   [Full Text] [Related]  

  • 4. Practice and Educational Gaps in Lupus, Dermatomyositis, and Morphea.
    Fett NM; Fiorentino D; Werth VP
    Dermatol Clin; 2016 Jul; 34(3):243-50. PubMed ID: 27363879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimalarial drug toxicities in patients with cutaneous lupus and dermatomyositis: A retrospective cohort study.
    Mittal L; Zhang L; Feng R; Werth VP
    J Am Acad Dermatol; 2018 Jan; 78(1):100-106.e1. PubMed ID: 28989103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse cutaneous reactions to hydroxychloroquine are more common in patients with dermatomyositis than in patients with cutaneous lupus erythematosus.
    Pelle MT; Callen JP
    Arch Dermatol; 2002 Sep; 138(9):1231-3; discussion 1233. PubMed ID: 12224986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The quinacrine experience in a population of patients with cutaneous lupus erythematosus and dermatomyositis.
    Mittal L; Werth VP
    J Am Acad Dermatol; 2017 Aug; 77(2):374-377. PubMed ID: 28711090
    [No Abstract]   [Full Text] [Related]  

  • 8. Photosensitivity in collagen vascular diseases.
    Callen JP
    Semin Cutan Med Surg; 1999 Dec; 18(4):293-6. PubMed ID: 10604795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The involvement of galectin-3 in skin injury in systemic lupus erythematosus patients.
    Shi Z; Meng Z; Han Y; Cao C; Tan G; Wang L
    Lupus; 2018 Apr; 27(4):621-627. PubMed ID: 29058991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous manifestations of selected rheumatologic diseases.
    Ostezan LB; Callen JP
    Am Fam Physician; 1996 Apr; 53(5):1625-36. PubMed ID: 8623690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case of anti-nuclear matrix protein 2 antibody-positive juvenile dermatomyositis preceded by linear cutaneous lupus erythematosus on the face.
    Miyahara H; Okiyama N; Okune M; Konishi R; Miyamoto M; Hara M; Iwabuchi A; Takada H; Nishino I; Nomura T
    J Dermatol; 2022 Jan; 49(1):e18-e19. PubMed ID: 34626009
    [No Abstract]   [Full Text] [Related]  

  • 12. Cutaneous manifestations of rheumatic diseases: lupus erythematosus, dermatomyositis, scleroderma.
    Sontheimer RD; Kovalchick P
    Dermatol Nurs; 1998 Apr; 10(2):81-95; quiz 96-7. PubMed ID: 9697441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cutaneous lupus erythematosus and skin manifestations in systemic lupus erythematosus].
    Sticherling M
    Z Rheumatol; 2013 Jun; 72(5):429-35. PubMed ID: 23743985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lupus erythematosus.
    Günther C; Wenzel J
    J Dtsch Dermatol Ges; 2023 Apr; 21(4):426-430. PubMed ID: 37070503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical FK506 (tacrolimus) therapy for facial erythematous lesions of cutaneous lupus erythematosus and dermatomyositis.
    Yoshimasu T; Ohtani T; Sakamoto T; Oshima A; Furukawa F
    Eur J Dermatol; 2002; 12(1):50-2. PubMed ID: 11809595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Skin manifestations of lupus erythematosus].
    Harr T; Bircher AJ; Häusermann P
    Ther Umsch; 2005 May; 62(5):303-12. PubMed ID: 15945221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Connective Tissue Disease: Current Concepts.
    Fernandez AP
    Dermatol Clin; 2019 Jan; 37(1):37-48. PubMed ID: 30466687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cutaneous lupus erythematosus, a multidimensional entity].
    Méndez-Flores S; Tinoco-Fragoso F; Hernández-Molina G
    Rev Med Inst Mex Seguro Soc; 2015; 53(6):764-72. PubMed ID: 26506497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subacute cutaneous lupus erythematosus and dermatomyositis associated with anti-programmed cell death 1 therapy.
    Marano AL; Clarke JM; Morse MA; Shah A; Barrow W; Selim MA; Hall RP; Cardones AR
    Br J Dermatol; 2019 Sep; 181(3):580-583. PubMed ID: 30244487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutis photo quiz. Lupus erythematosus and dermatomyositis.
    Eisner JM; English JC
    Cutis; 2001 Jan; 67(1):58, 77. PubMed ID: 11204606
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.